Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study

Author： Hatoum Hind T.   Lin Swu-Jane   Buchner Deborah   Kim Edward  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.6, 2011-06, pp. : 1255-1262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Musculoskeletal Symptoms in Patients With Cryopyrin‐Associated Periodic Syndromes: A Large Database Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 11, 2015-11 ,pp. : 3027-3036

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 463-463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombopoiesis‐stimulating agents and myelodysplastic syndromes

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 309-323

John Wiley & Sons Inc

Access to resources Recommend Favorite

Danazol Therapy for Thrombocytopenia in Patients with Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 107, Iss. 4, 2002-05 ,pp. : 234-236

Karger

Access to resources Recommend Favorite

Allogeneic haematopoietic cell transplantation with reduced‐intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 3, 2015-02 ,pp. : 463-466

John Wiley & Sons Inc

Access to resources Recommend Favorite